Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Cash flows from operating activities:
Net loss	$ (32,521)	$ (2,559)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,032	6,690
Amortization of debt issuance costs	108	108
Interest on financing liability	510	492
Deferred taxes	(50)	(1,008)
Stock-based compensation	1,099	1,459
Provision for losses on accounts receivable	312	258
Excess tax benefit on stock-based compensation	0	(101)
Loss (gain) on disposal of fixed assets	124	(97)
Decrease (increase) in operating assets:
Accounts receivable	18,219	24,578
Inventories	(8,123)	(8,312)
Other assets	1,311	6,637
(Decrease) increase in operating liabilities:
Accounts payable	(12,169)	(10,803)
Merger transaction costs	4,364	0
Litigation matters	8,100	0
Income taxes	2,475	(1,084)
Unearned revenues - current	(173)	110
Restructuring reserve	(1,093)	(1,414)
Other liabilities	(2,228)	(15,381)
Net cash used in operating activities	(13,703)	(427)
Cash flows from investing activities:
Acquisition of property, plant, and equipment and intangibles	(3,547)	(5,800)
Cash receipts on note receivable from sale of discontinued operations	519	71
Other investing activities	5	97
Net cash used in investing activities	(3,023)	(5,632)
Cash flows from financing activities:
Proceeds from stock issuances	280	104
Excess tax benefit on stock-based compensation	0	101
Net change in factoring and bank overdrafts	49	5
Payment of long-term debt	(53)	(28)
Proceeds from financing liability	0	1,121
Net cash provided by financing activities	276	1,303
Effect of foreign currency rate fluctuations on cash and cash equivalents	1,061	(6,576)
Net decrease in cash and cash equivalents	(15,389)	(11,332)
Cash and cash equivalents:
Beginning of period	124,289	135,537
End of period	$ 108,900	$ 124,205